4.6 Review

Considerations and challenges of islet transplantation and future therapies on the horizon

Related references

Note: Only part of the references are listed.
Article Surgery

The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program

Shareen Forbes et al.

Summary: The UK islet allotransplant program is nationally funded and provides one or two transplants to individuals with type 1 diabetes. Analysis shows that recipients of two transplants have higher graft survival over the first 12 months compared to recipients of one transplant, but function at 1 and 6 years is comparable. Minimizing the interval between 2 islet infusions may maximize cumulative impact on graft function.

AMERICAN JOURNAL OF TRANSPLANTATION (2022)

Article Surgery

Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes

James F. Markmann et al.

Summary: Allogeneic islet transplant is a safe and effective treatment option for patients with T1D, improving metabolic control and quality of life.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Review Surgery

Autoreactive T cell profiles are altered following allogeneic islet transplantation with alemtuzumab induction and re-emerging phenotype is associated with graft function

Shereen Sabbah et al.

Summary: The research indicates that there is no significant difference in the proportion of islet-specific T cell responses in different time periods after islet transplantation, but the types and phenotypes of responses change significantly. An IL-10-dominated response is associated with lower graft function, while an IFN-gamma-dominated response is linked to subsequent C-peptide level decrease.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Surgery

Fibroblast growth factor 7 releasing particles enhance islet engraftment and improve metabolic control following islet transplantation in mice with diabetes

Salamah M. Alwahsh et al.

Summary: Liver-targeted FGF7-GAL-PLGA particles were shown to enhance islet engraftment and improve blood glucose control in diabetic mice, with good safety profile. This targeted approach could be a promising strategy to optimize islet transplantation outcomes in type 1 diabetes.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Article Engineering, Biomedical

Enhancing islet transplantation using a biocompatible collagen-PDMS bioscaffold enriched with dexamethasone-microplates

Rosita Primavera et al.

Summary: Islet transplantation is a promising approach for type 1 diabetic patients, however, synthetic bioscaffolds can induce inflammation. By coating PDMS bioscaffolds with collagen and enriching them with DEX-microplates, inflammation can be reduced, leading to prolonged and enhanced islet function and survival.

BIOFABRICATION (2021)

Article Surgery

Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients

Paul N. Harden et al.

Summary: Using autologous polyclonal regulatory T cell therapy in kidney transplantation can reduce immunosuppression dosage, leading to improved long-term clinical outcomes with potentially lower rejection rates compared to standard immunosuppression.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Review Cell & Tissue Engineering

Protecting islet functional viability using mesenchymal stromal cells

Ella L. Hubber et al.

Summary: Islet transplantation is a promising treatment for type 1 diabetes, but faces challenges in maintaining islet viability. Co-culture with MSCs has shown to improve islet survival and function, potentially through secreted factors and even transfer of functional mitochondria to support beta cells.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Review Endocrinology & Metabolism

Effects of islet transplantation on microvascular and macrovascular complications in type 1 diabetes

Laura Reid et al.

Summary: Islet cell transplantation (ICT) is a recommended treatment option for individuals with debilitating hypoglycemia due to type 1 diabetes, aiming to improve glycemic control and reduce severe hypoglycemia. ICT may stabilize or improve microvascular complications, but its impact on macrovascular disease progression and long-term outcomes require further investigation.

DIABETIC MEDICINE (2021)

Review Biotechnology & Applied Microbiology

Engineering islets from stem cells for advanced therapies of diabetes

Johanna Siehler et al.

Summary: Diabetes is a significant global health concern affecting millions of people, and advanced therapies utilizing stem cell differentiation and islet engineering may offer potential breakthroughs in treatment. Research in these areas could lead to improved understanding of pancreatic function and provide new insights into diabetes mechanisms.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Cell Biology

A nanofibrous encapsulation device for safe delivery of insulin-producing cells to treat type 1 diabetes

Xi Wang et al.

Summary: The study introduces a novel device composed of nanofibers for transplanting stem cell-derived beta cells to treat T1D, demonstrating its safety, efficacy, and sustainability in animal experiments.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

Selective deletion of human leukocyte antigens protects stem cell-derived islets from immune rejection

Audrey Parent et al.

Summary: The use of genetic engineering to create hypoimmunogenic human pluripotent stem cells (hPSCs) has shown promise in reducing alloimmune rejection and allowing for better matching with recipients in the treatment of type 1 diabetes.

CELL REPORTS (2021)

Article Surgery

Co-localized immune protection using dexamethasone-eluting micelles in a murine islet allograft model

Purushothaman Kuppan et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Review Immunology

Mesenchymal Stromal Cells in Solid Organ Transplantation

Morgan Vandermeulen et al.

TRANSPLANTATION (2020)

Review Transplantation

Current status of porcine islet xenotransplantation

Taylor M. Coe et al.

CURRENT OPINION IN ORGAN TRANSPLANTATION (2020)

Review Public, Environmental & Occupational Health

Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis

Majid Mobasseri et al.

HEALTH PROMOTION PERSPECTIVES (2020)

Review Medicine, General & Internal

Advances in β-cell replacement therapy for the treatment of type 1 diabetes

Marie-Christine Vantyghem et al.

LANCET (2019)

Review Immunology

mTOR Inhibition and Clinical Transplantation: Pancreas and Islet

Thierry Berney et al.

TRANSPLANTATION (2018)

Review Endocrinology & Metabolism

The journey of islet cell transplantation and future development

Anissa Gamble et al.

ISLETS (2018)

Editorial Material Endocrinology & Metabolism

Islet transplantation in type 1 diabetes: moving forward

Shareen Forbes et al.

LANCET DIABETES & ENDOCRINOLOGY (2018)

Article Surgery

Purity of islet preparations and 5-year metabolic outcome of allogenic islet transplantation

K. Benomar et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2018)

Review Endocrinology & Metabolism

Clinical pancreatic islet transplantation

A. M. James Shapiro et al.

NATURE REVIEWS ENDOCRINOLOGY (2017)

Letter Medicine, General & Internal

Bioengineering of an Intraabdominal Endocrine Pancreas

David A. Baidal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Endocrinology & Metabolism

Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia

Bernhard J. Hering et al.

DIABETES CARE (2016)

Review Immunology

Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside

Chantal Kuhn et al.

IMMUNOTHERAPY (2016)

Article Endocrinology & Metabolism

Diabetes mellitus statistics on prevalence and mortality: facts and fallacies

Paul Zimmet et al.

NATURE REVIEWS ENDOCRINOLOGY (2016)

Review Ophthalmology

Interventions for Diabetic Retinopathy in Type 1 Diabetes: Systematic Review and Meta-Analysis

Sohaib A. Virk et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)

Article Biotechnology & Applied Microbiology

A prevascularized subcutaneous device-less site for islet and cellular transplantation

Andrew R. Pepper et al.

NATURE BIOTECHNOLOGY (2015)

Article Biochemistry & Molecular Biology

Generation of Functional Human Pancreatic β Cells In Vitro

Felicia W. Pagliuca et al.

Article Surgery

Everolimus with low-dose tacrolimus in simultaneous pancreas and kidney transplantation

Junichiro Sageshima et al.

CLINICAL TRANSPLANTATION (2014)

Review Endocrinology & Metabolism

Severe hypoglycaemia in type 1 diabetes mellitus: underlying drivers and potential strategies for successful prevention

S. A. Little et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2014)

Article Multidisciplinary Sciences

Beneficial Effect of Insulin Treatment on Islet Transplantation Outcomes in Akita Mice

Kazuhide Kikawa et al.

PLOS ONE (2014)

Article Cell & Tissue Engineering

Enhanced Oxygen Supply Improves Islet Viability in a New Bioartificial Pancreas

Uriel Barkai et al.

CELL TRANSPLANTATION (2013)

Article Materials Science, Biomaterials

Accelerating protein release from microparticles for regenerative medicine applications

Lisa J. White et al.

MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2013)

Article Cell & Tissue Engineering

The Effects of Digestion Enzymes on Islet Viability and Cellular Composition

Itzia Iglesias et al.

CELL TRANSPLANTATION (2012)

Review Endocrinology & Metabolism

Tolerance-Inducing Strategies in Islet Transplantation

Sumantha Bhatt et al.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2012)

Review Transplantation

Islet assessment for transplantation

Klearchos K. Papas et al.

CURRENT OPINION IN ORGAN TRANSPLANTATION (2009)

Article Endocrinology & Metabolism

Primary Graft Function, Metabolic Control, and Graft Survival After Islet Transplantation

Marie-Christine Vantyghem et al.

DIABETES CARE (2009)

Article Biotechnology & Applied Microbiology

Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo

Evert Kroon et al.

NATURE BIOTECHNOLOGY (2008)

Article Cell & Tissue Engineering

Toward maximizing the success rates of human islet isolation: Influence of donor and isolation factors

Gaston M. Ponte et al.

CELL TRANSPLANTATION (2007)

Article Medicine, General & Internal

International trial of the edmonton protocol for islet transplantation

A. M. James Shapiro et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Genetics & Heredity

Class-, gene-, and group-specific HLA silencing by lentiviral shRNA delivery

Constanca Figueiredo et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2006)

Article Endocrinology & Metabolism

Five-year follow-up after clinical islet transplantation

EA Ryan et al.

DIABETES (2005)

Article Medicine, General & Internal

Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes

BJ Hering et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Article Endocrinology & Metabolism

β-Score -: An assessment of β-cell function after islet transplantation

EA Ryan et al.

DIABETES CARE (2005)

Meeting Abstract Immunology

Stable knock down of non-acceptable HLA mismatches in solid organ transplantation

C Figueiredo et al.

HUMAN IMMUNOLOGY (2004)

Article Endocrinology & Metabolism

Severe hypoglycaemia in 1076 adult patients with type 1 diabetes:: influence of risk markers and selection

U Pedersen-Bjergaard et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2004)

Article Medicine, General & Internal

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

AMJ Shapiro et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)